DevCurationThe Premier Voice of the Entire Tech Ecosystem
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Home
Where the Money Moved
News
Events
Investor Spotlight
Company Spotlight
Frameworks
DevCuration
Latest
Curant.ai Raises $3.1M Seed for Insurance Claims AICurant.ai Raises $3.1M Seed for Insurance Claims AI|Align Ventures Closes Oversubscribed $125M Early-Stage Fund IIAlign Ventures Closes Oversubscribed $125M Early-Stage Fund II|Epitel Raises $26M to Expand Wireless EEG MonitoringEpitel Raises $26M to Expand Wireless EEG Monitoring|CORE Biomedicine Raises $21M Series A for Precision OncologyCORE Biomedicine Raises $21M Series A for Precision Oncology|KMM Group Takes RS2 Investment to Scale MedTech ManufacturingKMM Group Takes RS2 Investment to Scale MedTech Manufacturing|Ripple Invests in Notabene for Compliant Stablecoin PaymentsRipple Invests in Notabene for Compliant Stablecoin Payments|Tinicum Investment Backs GracoRoberts Aerospace PlatformTinicum Investment Backs GracoRoberts Aerospace Platform|Morgan Stanley Acquires Majority Stake in ConversicaMorgan Stanley Acquires Majority Stake in Conversica|PawPay Lands VANE Backing for Pet Insurance CheckoutPawPay Lands VANE Backing for Pet Insurance Checkout|Flourish Health Raises $26M Series A for Youth Mental HealthFlourish Health Raises $26M Series A for Youth Mental Health|Curant.ai Raises $3.1M Seed for Insurance Claims AICurant.ai Raises $3.1M Seed for Insurance Claims AI|Align Ventures Closes Oversubscribed $125M Early-Stage Fund IIAlign Ventures Closes Oversubscribed $125M Early-Stage Fund II|Epitel Raises $26M to Expand Wireless EEG MonitoringEpitel Raises $26M to Expand Wireless EEG Monitoring|CORE Biomedicine Raises $21M Series A for Precision OncologyCORE Biomedicine Raises $21M Series A for Precision Oncology|KMM Group Takes RS2 Investment to Scale MedTech ManufacturingKMM Group Takes RS2 Investment to Scale MedTech Manufacturing|Ripple Invests in Notabene for Compliant Stablecoin PaymentsRipple Invests in Notabene for Compliant Stablecoin Payments|Tinicum Investment Backs GracoRoberts Aerospace PlatformTinicum Investment Backs GracoRoberts Aerospace Platform|Morgan Stanley Acquires Majority Stake in ConversicaMorgan Stanley Acquires Majority Stake in Conversica|PawPay Lands VANE Backing for Pet Insurance CheckoutPawPay Lands VANE Backing for Pet Insurance Checkout|Flourish Health Raises $26M Series A for Youth Mental HealthFlourish Health Raises $26M Series A for Youth Mental Health
DevCuration

The premier voice of the tech ecosystem, from ideation to enterprise.

Explore

  • Where the Money Moved
  • Events
  • Articles & Analysis

Spotlights

  • Investor Spotlight
  • Company Spotlight
  • Frameworks

Company

  • About Us
  • Privacy Policy
  • Terms of Service
© 2026 DevCuration. All rights reserved.
TwitterLinkedIn
Logos provided by Logo.dev
Back to articles
July 30, 2026
•Jesse LandryJesse Landry

Frenos Raises $1.52M Seed Extension for AI-Native OT Security

Frenos has raised a $1.52M seed extension to expand customer success and AI research for its simulated operational technology penetration-testing platform. Momenta and Exposition Ventures co-led the round, Riptide Ventures participated, and Frenos says the financing brings its total funding to $6.4M.

The round matters because operational technology security has a physical-world constraint most software categories never face: testing a defense cannot be allowed to interrupt the system being defended. Frenos is betting that digital twins and AI-driven attack-path reasoning can give critical-infrastructure teams better evidence without making production equipment the laboratory.

What Happened

Frenos announced the seed extension on July 28, 2026. Momenta and Exposition Ventures co-led the investment, with Riptide Ventures joining the round. The company plans to grow its customer-success organization for critical-infrastructure and defense customers while expanding the AI R&D team behind its platform.

The financing follows Frenos' $3.88M seed round led by DataTribe in January 2025. Frenos now reports $6.4M in total funding, although the two public round announcements account for $5.4M and do not separately explain the remaining capital. That gap is worth keeping clean rather than filling with startup arithmetic performed by vibes.

The current Frenos leadership page lists Brian Proctor as Co-Founder and CEO, Harry Thomas as Co-Founder and CTO, and Eric Profittlich as Co-Founder and Board Member. Proctor built the company around a problem he encountered during more than a decade defending OT environments: vulnerability lists are long, but only a small subset of weaknesses can be combined into an attack path that reaches something important.

How Frenos Tests OT Without Touching Production

Frenos creates a digital twin of a customer's OT environment, then uses SAIRA, its AI reasoning agent, to simulate how an adversary could move through that model. The platform analyzes vulnerabilities, network conditions, tactics, and existing controls to identify feasible attack paths and prioritize mitigations. Because the testing occurs away from production, teams can investigate aggressive scenarios without scanning live industrial systems or introducing downtime.

That approach targets a structural weakness in OT cybersecurity. Traditional penetration tests can be disruptive, so they are often performed periodically and cautiously. Vulnerability scanners can generate large backlogs without explaining whether an attacker can chain those findings into an operational consequence. Frenos is trying to turn the question from "What is vulnerable?" into "What is defensible, what is reachable, and what reduces risk first?"

The company also announced SAIRA Co-Work, which it describes as a persistent OT security co-worker that reasons over live digital-twin data and guides investigations with evidence. The product direction moves Frenos from a point-in-time assessment tool toward a continuing decision layer. That is a more ambitious role, but it fits the operating reality: industrial environments change, adversary behavior changes, and a quarterly PDF ages with impressive speed.

Why Industrial Investors Are Leaning In

Momenta's investment rationale is unusually aligned with the product's constraint. The firm argues that OT security cannot depend on tools borrowed from IT when industrial operators must protect uptime, safety, and operational continuity. Frenos gives those operators a way to validate cyber resilience continuously without treating live equipment as a test bench.

Exposition Ventures brings an early-stage industrial-infrastructure lens, while Riptide Ventures focuses on companies serving regulated markets. That investor mix is useful because Frenos does not merely need capital to train models. It needs help navigating buyers who are cautious for good reason, sales cycles shaped by operational risk, and deployments where technical credibility matters more than theatrical AI language.

Frenos says its commercial metrics are moving in the right direction. The company reports ARR at more than 10x its level at the start of 2025, including 215% growth in the first half of 2026. It also reports pipeline growth of 2.7x year over year, a 5x increase in average deal size, and 2026 bookings already at 4x full-year 2025 with five months remaining. These figures are company-reported and not independently audited, but they explain why the extension is framed around customer success and deeper product development rather than basic market discovery.

The Signal Behind 12,000 Findings

The clearest product example in the announcement is also the least glamorous, which is usually where enterprise value hides. In one customer environment, Frenos says SAIRA analyzed more than 12,000 OT vulnerability findings and identified eight that were exploitable under the modeled network's actual conditions. The company reports that this reduced remediation noise by 99.9%.

That does not prove every deployment will produce the same result, and the metric comes from Frenos rather than an independent evaluation. It does illustrate the product thesis in plain terms. An industrial team with 12,000 findings has a data problem; a team that knows which eight can form a real attack path has a decision.

The timing also extends beyond startup positioning. In May 2026, the Google Threat Intelligence Group reported identifying a threat actor using a zero-day exploit it believed was developed with AI, alongside broader evidence of AI-assisted vulnerability research and attack operations. Faster offensive experimentation raises the cost of relying on slow, episodic defensive validation.

What This Funding Signals

The $1.52M extension is small by growth-round standards, but its strategic shape is clear. Frenos is adding customer-success capacity while investing in the AI system that makes the product differentiated. One team helps industrial buyers turn findings into operational changes; the other improves the reasoning engine that decides which findings deserve attention.

For operators, the relevant question is not whether an OT security product uses AI. The question is whether it can produce evidence that survives contact with engineers, safety requirements, and production constraints. Frenos has designed around that burden from the start, using digital twins to keep simulated attacks away from live systems.

For investors, the round is a bet that continuous validation becomes a distinct layer in the OT security stack. Monitoring tells teams what exists and detection tools flag activity, but neither automatically proves which path an adversary can complete. If Frenos can keep turning noisy vulnerability inventories into defensible priorities, the company will be selling something industrial buyers understand immediately: fewer guesses, safer tests, and clearer decisions.

Frequently Asked Questions

What will Frenos do with the $1.52M seed extension?

Frenos says it will expand customer success for critical-infrastructure and defense customers and grow the AI R&D team behind SAIRA and its simulated penetration-testing platform.

Who invested in Frenos' seed extension?

Momenta and Exposition Ventures co-led the round, and Riptide Ventures participated.

How does Frenos test OT security without disrupting production?

Frenos builds a digital twin of the OT environment and uses its SAIRA reasoning agent to simulate adversary attack paths away from live systems. The model is designed to help teams prioritize mitigations without scanning or testing against production equipment.

How much funding has Frenos raised?

Frenos reports $6.4M in total funding. Its reviewed public announcements disclose a $3.88M seed round in January 2025 and a $1.52M seed extension in July 2026, but they do not separately explain the difference between those disclosed amounts and the reported total.

Why does continuous OT security validation matter?

Industrial systems prioritize safety and uptime, which can make frequent live testing risky. A digital-twin approach can let teams investigate attack paths and prioritize mitigations without touching production.

Back to all articles
Newsletter

Where the Money Moved

The intelligence briefing of the innovation economy — funding, M&A, debt and fund closes, read as market signal rather than deal announcements.

Subscribe on wherethemoneymoved.com
Frenos

Frenos

Simulated operational technology penetration testing platform

WebsiteLinkedIn

Key Executives

  • Brian Proctor
  • CEO; Harry Thomas
+1 more (coming soon)

Investors

MomentaExposition Ventures

Related Articles

Where the Money Moved
Curant.ai Raises $3.1M Seed for Insurance Claims AI
Jul 30, 2026
Where the Money Moved
Antares Labs Raises $7.25M Seed for Real Estate AI
Jul 30, 2026
Where the Money Moved
Aurenar Raises $5.7M Seed to Advance V-Link Neurotech
Jul 29, 2026
Where the Money Moved
Credible Data Raises $10M Seed for Enterprise AI Context
Jul 29, 2026
Where the Money Moved
Freight Hero Raises $5M Seed to Automate Freight Operations
Jul 28, 2026

More from Jesse Landry

Where the Money Moved
Align Ventures Closes Oversubscribed $125M Early-Stage Fund II
Jul 30, 2026
Where the Money Moved
Epitel Raises $26M to Expand Wireless EEG Monitoring
Jul 30, 2026

Trending

News
Alpaca and Vacuumlabs Link European Fintech Infrastructure
Jul 29, 2026
Events
StrictlyVC NYC 2026 Brings Venture Signal to One Room
Jul 29, 2026
Company Spotlight
Okta
Jul 29, 2026
Investor Spotlight
Sapphire Ventures
Jul 29, 2026
View all posts